dc.contributor.author
Leonhardt, Silke
dc.contributor.author
Veltzke-Schlieker, Wilfried
dc.contributor.author
Adler, Andreas
dc.contributor.author
Schott, Eckart
dc.contributor.author
Eurich, Dennis
dc.contributor.author
Faber, Wladimir
dc.contributor.author
Neuhaus, Peter
dc.contributor.author
Seehofer, Daniel
dc.date.accessioned
2018-06-08T03:13:56Z
dc.date.available
2016-03-17T12:24:36.529Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/14742
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-18932
dc.description.abstract
Secondary sclerosing cholangitis in critically ill patients (SSC-CIP) is an
important differential diagnosis in patients presenting with cholestasis and
PSC-like cholangiographic changes in endoscopic retrograde cholangiography
(ERC). As a relatively newly described entity, SSC-CIP is still
underdiagnosed, and the diagnosis is often delayed. The present study aims to
improve the early detection of SSC-CIP and the identification of its
complications. A total of 2633 records of patients who underwent or were
listed for orthotopic liver transplantation at the University Hospital
Charité, Berlin, were analyzed retrospectively. The clinical presentation and
outcome (mean follow-up 62.7 months) of the 16 identified SSC-CIP cases were
reviewed. Cholestasis was the first sign of SSC-CIP. GGT was the predominant
enzyme of cholestasis. Hypercholesterolemia occurred in at least 75% of the
patients. SSC-CIP provoked a profound weight loss (mean 18 kg) in 94% of our
patients. SSC-CIP was diagnosed by ERC in all patients. The 3 different
cholangiographic features detected correspond roughly to the following stages:
(I) evidence of biliary casts, (II) progressive destruction of intrahepatic
bile ducts, and (III) picture of pruned tree. Biliary cast formation is a
hallmark of SSC-CIP and was seen in 87% of our cases. In 75% of the patients,
the clinical course was complicated by cholangiosepsis, cholangitic liver
abscesses, acalculous cholecystitis, or gallbladder perforation. SSC-CIP was
associated with worse prognosis; transplant-free survival was ∼40 months
(mean). Because of its high rate of serious complications and unfavorable
prognosis, it is imperative to diagnose SSC-CIP early and to differentiate
SSC-CIP from other types of sclerosing cholangitis. Specific characteristics
enable identification of SSC-CIP. Early cooperation with a transplant center
and special attention to biliary complications are required after diagnosis of
SSC-CIP.
en
dc.rights.uri
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Secondary Sclerosing Cholangitis in Critically Ill Patients
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Medicine. - 94 (2015), 49, Artikel Nr. e2188
dc.title.subtitle
Clinical Presentation, Cholangiographic Features, Natural History, and
Outcome: A Series of 16 Cases
dcterms.bibliographicCitation.doi
10.1097/MD.0000000000002188
dcterms.bibliographicCitation.url
http://journals.lww.com/md-journal/pages/articleviewer.aspx?year=2015&issue=12080&article=00027&type=abstract
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000024181
refubium.note.author
Der Artikel wurde in einer Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000006123
dcterms.accessRights.openaire
open access